Literature DB >> 18991024

Pheochromocytoma: time to stamp out "malignancy"?

Arthur S Tischler.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18991024     DOI： 10.1007/s12022-008-9047-x

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN： 1046-3976            Impact factor:   3.943


× No keyword cloud information.
  2 in total

1.  Clinical experience over 48 years with pheochromocytoma.

Authors:  R E Goldstein; J A O'Neill; G W Holcomb; W M Morgan; W W Neblett; J A Oates; N Brown; J Nadeau; B Smith; D L Page; N N Abumrad; H W Scott
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

Review 2.  Malignant pheochromocytoma: current status and initiatives for future progress.

Authors:  Graeme Eisenhofer; Stefan R Bornstein; Frederieke M Brouwers; Nai-Kong V Cheung; Patricia L Dahia; Ronald R de Krijger; Thomas J Giordano; Lloyd A Greene; David S Goldstein; Hendrik Lehnert; William M Manger; John M Maris; Hartmut P H Neumann; Karel Pacak; Barry L Shulkin; David I Smith; Arthur S Tischler; William F Young
Journal:  Endocr Relat Cancer       Date:  2004-09       Impact factor: 5.678
  2 in total
  11 in total

Review 1.  Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.

Authors:  Graeme Eisenhofer; Arthur S Tischler; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

Review 2.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

3.  Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma.

Authors:  Sachiko Konosu-Fukaya; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Yayoi Aoyama; Fumitoshi Satoh; Fumiyoshi Fujishima; Hironobu Sasano; Yasuhiro Nakamura
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

4.  A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.

Authors:  Alexander Kroiss; Daniel Putzer; Andreas Frech; Clemens Decristoforo; Christian Uprimny; Rudolf Wolfgang Gasser; Barry Lynn Shulkin; Christoph Url; Gerlig Widmann; Rupert Prommegger; Georg Mathias Sprinzl; Gustav Fraedrich; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236

5.  (68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT.

Authors:  Alexander Kroiss; Barry Lynn Shulkin; Christian Uprimny; Andreas Frech; Rudolf Wolfgang Gasser; Christoph Url; Kurt Gautsch; Ruth Madleitner; Bernhard Nilica; Georg Mathias Sprinzl; Guenther Gastl; Gustav Fraedrich; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-19       Impact factor: 9.236

6.  Metastatic pheochromocytoma: does the size and age matter?

Authors:  Tomáš Zelinka; Zdeněk Musil; Jaroslava Dušková; Deborah Burton; Maria J Merino; Dragana Milosevic; Jiří Widimský; Karel Pacak
Journal:  Eur J Clin Invest       Date:  2011-04-01       Impact factor: 4.686

Review 7.  Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Authors:  Aoife J Lowery; Siun Walsh; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-04-10

8.  A large pheochromocytoma with invasion of multiple local organs.

Authors:  Daming Zhu; Ajith Kumar; William S Weintraub; Ehsanur Rahman
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-01       Impact factor: 3.738

9.  Pheochromocytoma and paraganglioma: current functional and future molecular imaging.

Authors:  Elise M Blanchet; Victoria Martucci; Karel Pacak
Journal:  Front Oncol       Date:  2012-01-06       Impact factor: 6.244

10.  Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy.

Authors:  Lucia Martiniova; Jie Lu; Jeffrey Chiang; Marcelino Bernardo; Russell Lonser; Zhengping Zhuang; Karel Pacak
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.